| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 83.57× | 83.57× | 211.14× | 130.71× | 97.05× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.23× | 0.23× | 0.12× | 0.20× | 0.25× | ||
| 4.47× | 4.47× | −0.62× | −0.51× | −0.03× | ||
| −14.02× | −14.02× | 3.18× | −4.50× | −0.06× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 97.05 | 130.71 | 211.14 | 83.57 | 83.57 | |
| Asset Turnover | 0.25 | 0.20 | 0.12 | 0.23 | 0.23 | |
| Cash Conversion (CFO/Net Income) | -0.03 | -0.51 | -0.62 | 4.47 | 4.47 | |
| CFO/EBITDA | -0.06 | -4.50 | 3.18 | -14.02 | -14.02 |